1177-8881
Published by: Dove Medical Press
https://www.dovepress.com/drug-design-development-and-therapy-journal
| Discipline name | Position | Best Scientists | Publications | D-Index |
|---|---|---|---|---|
| Chemistry | 522 | 39 | 44 | 15 |
| Medicine | 1220 | 53 | 48 | 20 |
Drug Design Development and Therapy is organized to address concerns in the fields of Pharmacology, Internal medicine, Cancer research, In vivo and Pharmacokinetics. It explores topics in Pharmacology which can be helpful for research in disciplines like Inflammation, Oxidative stress and Drug delivery. The Internal medicine works featured in the journal incorporate elements from Gastroenterology, Endocrinology and Oncology.
In the journal, Cancer cell, Cancer, Cell growth and Apoptosis, PI3K/AKT/mTOR pathway are investigated in conjunction with one another to address concerns in Cancer research research. Viability assay is a major topic of Apoptosis research presented in Drug Design Development and Therapy. Drug Design Development and Therapy focused on In vivo research but expanded to cover In vitro.
It explores issues in Pharmacokinetics which can be linked to other research areas like Tolerability, Chromatography, Crossover study and Bioavailability.
The journal papers mainly deal with areas of study such as Pharmacology, Internal medicine, Oncology, Cancer research and Clinical trial. Issues in Pharmacology were discussed in the journal papers, taking into consideration concepts from other disciplines like Biochemistry, Drug delivery and In vivo. The published articles explore issues in Internal medicine which can be linked to other research areas like Gastroenterology, Endocrinology, Surgery and Immunology.
Drug Design Development and Therapy facilitates discussions on Pharmacology, Internal medicine, Cancer research, Apoptosis and Pharmacokinetics. It tackles studies in Signal transduction and the interrelated subject of KEGG to gain insights into Pharmacology. Drug Design Development and Therapy holds forums on Internal medicine that merges themes from other disciplines such as Gastroenterology, Endocrinology and Oncology.
The presented Cancer research research provided insight into the related
A key indicator for each journal is its effectiveness in reaching other researchers with the papers published at that venue.
The chart below presents the interquartile range (first quartile 25%, median 50% and third quartile 75%) of the number of citations of articles over time.
The top authors publishing in Drug Design Development and Therapy (based on the number of publications) are:
The overall trend for top authors publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top authors.
Only papers with recognized affiliations are considered
The top affiliations publishing in Drug Design Development and Therapy (based on the number of publications) are:
The overall trend for top affiliations publishing in this journal is outlined below. The chart shows the number of publications at each edition of the journal for top affiliations.
The publication chance index shows the ratio of articles published by the best research institutions in the journal edition to all articles published within that journal. The best research institutions were selected based on the largest number of articles published during all editions of the journal.
The chart below presents the percentage ratio of articles from top institutions (based on their ranking of total papers).Top affiliations were grouped by their rank into the following tiers: top 1-10, top 11-20, top 21-50, and top 51+. Only articles with a recognized affiliation are considered.
During the most recent 2021 edition, 8.13% of publications had an unrecognized affiliation. Out of the publications with recognized affiliations, 22.30% were posted by at least one author from the top 10 institutions publishing in the journal. Another 11.80% included authors affiliated with research institutions from the top 11-20 affiliations. Institutions from the 21-50 range included 20.00% of all publications and 45.90% were from other institutions.
A very common phenomenon observed among researchers publishing scientific articles is the intentional selection of journals they have already attended in the past. In particular, it is worth analyzing the case when the authors participate in the same journal from year to year.
The Returning Authors Index presented below illustrates the ratio of authors who participated in both a given as well as the previous edition of the journal in relation to all participants in a given year.
The graph below shows the Returning Institution Index, illustrating the ratio of institutions that participated in both a given and the previous edition of the conference in relation to all affiliations present in a given year.
Our experience to innovation index was created to show a cross-section of the experience level of authors publishing in a journal. The index includes the authors publishing at the last edition of a journal, grouped by total number of publications throughout their academic career (P) and the total number of citations of these publications ever received (C).
The group intervals were selected empirically to best show the diversity of the authors' experiences, their labels were selected as a convenience, not as judgment. The authors were divided into the following groups:
The chart below illustrates experience levels of first authors in cases of publications with multiple authors.
Brooke Benner;Logan Good;Dionisia Quiroga;Thomas E Schultz
(2020)Jinjing Wu;Yanli Yang;Yafen Gao;Zhaoqi Wang
(2020)James B Bussel;Gerald Soff;Adriana Balduzzi;Nichola Cooper
(2021)Milo Gatti;Massimo Andreoni;Federico Pea;Pierluigi Viale
(2021)Magdalena Rudzińska;Cenk Daglioglu;Lyudmila V Savvateeva;Fatma Necmiye Kaci
(2021)Gregory M Pastores;Derralynn A Hughes
(2020)Arianna Burton;Adam Castaño;Marianna Bruno;Steve Riley
(2021)For those interested in healthcare but exploring paths beyond traditional medical degrees, several related online options offer flexible routes into the field. For instance, an lpn fast track program provides a quicker route to becoming a Licensed Practical Nurse, opening doors to hands-on patient care roles without the time investment of an MD.
Advanced nursing professionals might consider pursuing one of the cheapest dnp programs available online. These Doctor of Nursing Practice degrees combine affordability with high-level training, enhancing career prospects in clinical practice and leadership.
Alternatively, careers in healthcare administration and support are in demand, especially with expertise in medical coding and billing. There are many online schools offering options with financial support, such as those listed under financial aid for medical billing and coding online classes, which make certification accessible and affordable.
For students majoring in biology, understanding the breadth of opportunities is key. Some pursue highly rewarding roles in research, biotechnology, or healthcare, highlighted in the article on high paying jobs with a biology degree. These paths can complement medical studies or serve as alternative career routes within life sciences.
